Will the VLA15 Lyme Disease vaccine "pass" its phase 3 human trial? | Manifold

Will the VLA15 Lyme Disease vaccine "pass" its phase 3 human trial?

100

1.7kṀ4230

2026

62%

chance

1H

6H

1D

1W

1M

ALL

I will defer resolution value to reputable news organizations

Ancient Markets

Get

1,000

to start trading!

People are also trading

Will an H5N1 mRNA vaccine be developed and enter "late stage" human trials (or wider release) by July 2025?

Will a vaccine for Lyme disease be available to the US public by the end of 2025?

Will FDA approve any mRNA vaccine against Lyme disease before 2028?

Will the M72/AS01E tuberculosis vaccine candidate have an efficacy of 50% or higher in the phase 3 trial?

Will an mRNA HIV vaccine pass Phase 2 trials by 2025

Will a dengue vaccine based on TV003/TV005 be approved before 2050?

Will the Phase 3 Trials of Olpasiran be a Success?

Will AOH1996 succeed in Phase I trial?

Will LOY-001 establish efficacy?

Will the Phase 2 Trials of Lepodisiran be a Success?

Related questions

Will an H5N1 mRNA vaccine be developed and enter "late stage" human trials (or wider release) by July 2025?

Will a vaccine for Lyme disease be available to the US public by the end of 2025?

Will FDA approve any mRNA vaccine against Lyme disease before 2028?

Will the M72/AS01E tuberculosis vaccine candidate have an efficacy of 50% or higher in the phase 3 trial?

Will an mRNA HIV vaccine pass Phase 2 trials by 2025

Will a dengue vaccine based on TV003/TV005 be approved before 2050?

Will the Phase 3 Trials of Olpasiran be a Success?

Will AOH1996 succeed in Phase I trial?

Will LOY-001 establish efficacy?

Will the Phase 2 Trials of Lepodisiran be a Success?

© Manifold Markets, Inc.•Terms•Privacy